​

LifeStance Health Group (LFST) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

LFST Stock Forecast

LifeStance Health Group (LFST) stock forecast, based on 8 Wall Street analysts, predicts a 12-month average price target of $8.50, with a high of $8.50 and a low of $8.50. This represents a 56.83% increase from the last price of $5.42.

$4 $5 $6 $7 $8 $9 High: $8.5 Avg: $8.5 Low: $8.5 Last Closed Price: $5.42

LFST Stock Rating

LifeStance Health Group stock's rating consensus is Buy, based on 8 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (75.00%), 1 Hold (12.50%), 1 Sell (12.50%), and 0 Strong Sell (0.00%).

Buy
Total 8 0 1 1 6 Strong Sell Sell Hold Buy Strong Buy

LFST Price Target Upside V Benchmarks

TypeNameUpside
StockLifeStance Health Group56.83%
SectorHealthcare Stocks 23.68%
IndustryMedical Care Facilities Stocks13.82%

Price Target Trends

1M3M12M
# Anlaysts111
Avg Price Target$8.50$8.50$8.50
Last Closing Price$5.42$5.42$5.42
Upside/Downside56.83%56.83%56.83%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 25251--8
May, 25242--8
Apr, 25222--6
Mar, 25222--6
Feb, 25222--6
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 27, 2025Kevin CaliendoUBS$8.50$6.0640.26%56.83%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 27, 2025UBSBuyupgrade
Dec 16, 2024Goldman SachsNeutralBuyupgrade
Feb 28, 2024William BlairOutperformOutperformhold
Nov 22, 2023Goldman SachsNeutralNeutralhold
Jan 06, 2023Morgan StanleyOverweightupgrade
Apr 28, 2022JefferiesBuyBuyhold

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-0.94$-0.61$-0.51$-0.15--
Avg Forecast$-0.87$-0.61$-0.48$-0.17$-0.13$-0.02
High Forecast$-0.85$-0.60$-0.46$-0.16$-0.08$0.01
Low Forecast$-0.89$-0.61$-0.49$-0.17$-0.18$-0.05
Surprise %8.05%-6.25%-11.76%--

Revenue Forecast

$650M $840M $1B $1B $1B $2B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$667.51M$859.54M$1.06B$1.25B--
Avg Forecast$668.47M$846.42M$1.04B$1.24B$1.39B$1.58B
High Forecast$678.78M$854.68M$1.05B$1.25B$1.41B$1.58B
Low Forecast$658.91M$837.73M$1.03B$1.23B$1.38B$1.58B
Surprise %-0.14%1.55%1.74%0.95%--

Net Income Forecast

$-350M $-270M $-190M $-110M $-30M $50M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-307.20M$-215.56M$-186.26M$-57.44M--
Avg Forecast$-319.77M$-222.68M$-175.90M$-61.60M$-54.26M$-7.77M
High Forecast$-313.82M$-219.71M$-170.23M$-60.24M$-30.90M$2.03M
Low Forecast$-326.18M$-225.50M$-181.58M$-62.97M$-65.24M$-17.57M
Surprise %-3.93%-3.20%5.89%-6.75%--

LFST Forecast FAQ

Is LifeStance Health Group stock a buy?

LifeStance Health Group stock has a consensus rating of Buy, based on 8 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 1 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that LifeStance Health Group is a favorable investment for most analysts.

What is LifeStance Health Group's price target?

LifeStance Health Group's price target, set by 8 Wall Street analysts, averages $8.5 over the next 12 months. The price target range spans from $8.5 at the low end to $8.5 at the high end, suggesting a potential 56.83% change from the previous closing price of $5.42.

How does LifeStance Health Group stock forecast compare to its benchmarks?

LifeStance Health Group's stock forecast shows a 56.83% upside, outperforming the average forecast for the healthcare stocks sector (23.68%) and outperforming the medical care facilities stocks industry (13.82%).

What is the breakdown of analyst ratings for LifeStance Health Group over the past three months?

  • June 2025: 25.00% Strong Buy, 62.50% Buy, 12.50% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 25.00% Strong Buy, 50.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 33.33% Strong Buy, 33.33% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.

What is LifeStance Health Group’s EPS forecast?

LifeStance Health Group's average annual EPS forecast for its fiscal year ending in December 2025 is $-0.13, marking a -13.33% decrease from the reported $-0.15 in 2024. Estimates for the following years are.

What is LifeStance Health Group’s revenue forecast?

LifeStance Health Group's average annual revenue forecast for its fiscal year ending in December 2025 is $1.39B, reflecting a 10.98% increase from the reported $1.25B in 2024. The forecast for.

What is LifeStance Health Group’s net income forecast?

LifeStance Health Group's net income forecast for the fiscal year ending in December 2025 stands at $-54.257M, representing a -5.55% decrease from the reported $-57.443M in 2024. Projections indicate .